Cosmos Health Inc. (COSM)
CIK 1474167 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 54.4M shares as of May 18, 2026 (10-Q). Share count fell from 126.9M to 12.8M between Nov 20, 2017 and Apr 17, 2018, a pattern consistent with a reverse split (roughly 1-for-10); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Issuance of Warrants | not tagged | $2.75 | — | — |
Tranches exactly as the company dimensioned them in its 10-K filed Apr 15, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.
Convertible notes
Convertible debt on the balance sheet: $10.1M as of Mar 31, 2026, tagged only as a company-wide total.
This filer tagged totals without per-note dimensions in its 10-Q filed May 20, 2026 →, so per-note terms (maturities, individual conversion prices) live in the exhibit prose and are not parsed here.
Registrations and offerings
Last 12 months: 0 executed · 6 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full COSM workspace